−135KRW
−2.95 BKRW
27.01 BKRW
14.97 M
About GENOFOCUS
Sector
Industry
CEO
Eui-Joong Kim
Website
Headquarters
Daejeon
Employees (FY)
66
Founded
2000
ISIN
KR7187420005
FIGI
BBG008H537V9
GenoFocus, Inc. engages the research and development of technologies related to biochemical and biotechnology industry. Its products include enzymes for food, animal, bioconversion and edible vaccines. In addition, It also provides technical services such as library generation, high-throughput screening and consulting services. The company was founded by Pan Jae-Gu, Choi Soo-Geun and Jung Heung-Chae on March 29, 2000 and is headquartered in Daejeon, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 187420 is 3895.00 KRW — it has increased by 2.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOFOCUS stocks are traded under the ticker 187420.
Yes, you can track GENOFOCUS financials in yearly and quarterly reports right on TradingView.
Like other stocks, 187420 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOFOCUS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 66.00 employees. See our rating of the largest employees — is GENOFOCUS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOFOCUS EBITDA is −4.82 B KRW, and current EBITDA margin is −17.86%. See more stats in GENOFOCUS financial statements.